ISLAMABAD: Who is encouraging the online sale of illegal and unregistered medicines in Pakistan? This question arises after the Drug Regulatory Authority of Pakistan urged the Pakistan Telecommunication Authority (PTA) to take action against this unlawful trade.
Meanwhile, DRAP is set to launch a crackdown on the rising online sale and promotion of unregistered and smuggled medicines, according to reports on Tuesday.
As part of the move, DRAP has formally requested the Pakistan Telecommunication Authority to block several websites and social media platforms allegedly involved in the illegal trade. Officials described the activity as a serious threat to public health, citing the unchecked availability of unapproved therapeutic products.
DRAP’s Division of Quality Assurance and Laboratory Testing identified multiple online platforms engaged in selling unregistered medicines. These include products marketed for sexual health, weight loss, and other medical conditions, many of which are being aggressively promoted through digital channels.
According to officials from the Ministry of National Health Services, the action follows a surge in online marketing of prescription-only drugs and psychotropic substances. These products are often advertised directly to consumers via social media, websites, and messaging platforms without proper regulatory approval.
Authorities warned that such practices encourage self-medication without consultation from qualified healthcare professionals, violating national drug laws and exposing consumers to significant health risks. Moreover, DRAP noted that it had received multiple public complaints regarding websites involved in selling unregistered therapeutic goods, prompting urgent action under legal provisions.
In separate communications, the regulator also flagged social media accounts on platforms like Facebook and Instagram that are allegedly engaged in marketing these products directly to users.
Furthermore, DRAP has urged citizens to avoid purchasing medicines from unauthorized sources and cautioned pharmacies against stocking or selling such products. It warned that strict legal action will be taken against violators to ensure compliance and safeguard public health.
